VYNDAMAX Trademark

Trademark Overview

On Thursday, January 3, 2019, a trademark application was filed for VYNDAMAX with the United States Patent and Trademark Office. The USPTO has given the VYNDAMAX trademark a serial number of 88248161. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, June 3, 2025. This trademark is owned by Wyeth LLC. The VYNDAMAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders
vyndamax

General Information

Serial Number88248161
Word MarkVYNDAMAX
Filing DateThursday, January 3, 2019
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, June 3, 2025
Registration Number5916587
Registration DateTuesday, November 19, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 24, 2019
Primary Code005
First Use Anywhere DateMonday, September 9, 2019
First Use In Commerce DateMonday, September 9, 2019

Trademark Owner History

Party NameWyeth LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10001-2192
Party NameWyeth LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10017
Party NameWyeth LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, January 7, 2019NEW APPLICATION ENTERED
Wednesday, March 27, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 7, 2019PUBLISHED FOR OPPOSITION
Thursday, January 24, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 21, 2019ASSIGNED TO EXAMINER
Wednesday, April 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 7, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 24, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, July 2, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 24, 2019USE AMENDMENT FILED
Tuesday, October 15, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 15, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 15, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, October 16, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, March 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 19, 2019REGISTERED-PRINCIPAL REGISTER
Monday, March 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 10, 2025TEAS SECTION 8 & 15 RECEIVED
Tuesday, June 3, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 3, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, June 3, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, November 19, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

vyndamax diseases disorders cardiovascular treatment preparations pharmaceutical